CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation

Journal of Immunology

Volumn 190, Issue 7, 2013, Pages 3696-3705

  Giegold, Oliver ^a   Ogrissek, Nadine ^a   Richter, Cornelia ^b   Schröder, Matthias ^c   San Juan, Martina Herrero ^a   Pfeilschifter, Josef M ^a   Radeke, Heinfried H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CXCL9 CHEMOKINE; PROTEIN KINASE B; RAC PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CHEMOTAXIS; CONTROLLED STUDY; DESENSITIZATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VIVO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ANIMALS; CALCIUM; CHEMOKINE CXCL12; CHEMOKINE CXCL9; CHEMOTAXIS; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RAC GTP-BINDING PROTEINS; RECEPTORS, CXCR3; RECEPTORS, CXCR4; T-LYMPHOCYTES; TH1 CELLS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84875432254     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101293     Document Type: Article

References (50)

1. Campbell, D. J., C. H. Kim, and E. C. Butcher. 2003. Chemokines in the systemic organization of immunity. Immunol. Rev. 195: 58-71.
2. Charo, I. F., and R. M. Ransohoff. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354: 610-621.
3. Iwamoto, T., H. Okamoto, Y. Toyama, and S. Momohara. 2008. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J. 275: 4448-4455.
4. Burman, A., O. Haworth, D. L. Hardie, E. N. Amft, C. Siewert, D. G. Jackson, M. Salmon, and C. D. Buckley. 2005. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J. Immunol. 174: 1693-1700.
5. Elyaman, W., P. Kivisäkk, J. Reddy, T. Chitnis, K. Raddassi, J. Imitola, E. Bradshaw, V. K. Kuchroo, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2008. Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis. Am. J. Pathol. 173: 411-422.
6. Fox, R. J., P. Kivisakk, E. Fisher, B. Tucky, J. C. Lee, R. A. Rudick, and R. M. Ransohoff. 2008. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury. Mult. Scler. 14: 1036-1043.
7. Kohler, R. E., I. Comerford, S. Townley, S. Haylock-Jacobs, I. Clark-Lewis, and S. R. McColl. 2008. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol. 18: 504-516.
8. Vanbervliet, B., N. Bendriss-Vermare, C. Massacrier, B. Homey, O. de Bouteiller, F. Brière, G. Trinchieri, and C. Caux. 2003. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198: 823-830.
9. Rivino, L., M. Messi, D. Jarrossay, A. Lanzavecchia, F. Sallusto, and J. Geginat. 2004. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J. Exp. Med. 200: 725-735.
10. Basu, S., and H. E. Broxmeyer. 2009. CCR5 ligands modulate CXCL12-induced chemotaxis, adhesion, and Akt phosphorylation of human cord blood CD34+ cells. J. Immunol. 183: 7478-7488.
11. Hecht, I., L. Cahalon, R. Hershkoviz, A. Lahat, S. Franitza, and O. Lider. 2003. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. Int. Immunol. 15: 29-38.
12. Honczarenko, M., Y. Le, A. M. Glodek, M. Majka, J. J. Campbell, M. Z. Ratajczak, and L. E. Silberstein. 2002. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood 100: 2321-2329.
13. Radeke, H. H., T. Tschernig, A. Karulin, G. Schumm, S. N. Emancipator, K. Resch, and M. Tary-Lehmann. 2002. CD4+ T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like kidney injury. Clin. Immunol. 104: 161-173.
14. Rubant, S., R. J. Ludwig, J. Pfeffer, P. Schulze-Johann, R. Kaufmann, J. M. Pfeilschifter, W. H. Boehncke, and H. H. Radeke. 2006. Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo. Exp. Dermatol. 15: 634-642.
15. Radeke, H. H., R. J. Ludwig, and W. H. Boehncke. 2005. Experimental approaches to lymphocyte migration in dermatology in vitro and in vivo. Exp. Dermatol. 14: 641-666.
16. Radeke, H. H., H. von Wenckstern, K. Stoidtner, B. Sauer, S. Hammer, and B. Kleuser. 2005. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J. Immunol. 174: 2778-2786.
17. Giegold, O., R. J. Ludwig, K. Hardt, J. Will, M. P. Schön, G. J. Oostingh, J. M. Pfeilschifter, W. H. Boehncke, and H. H. Radeke. 2009. Computer-aided analysis of cell interactions under dynamic flow conditions. Exp. Dermatol. 18: 238-245.
18. Grynkiewicz, G., M. Poenie, and R. Y. Tsien. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
19. Ding, Z., T. B. Issekutz, G. P. Downey, and T. K. Waddell. 2003. L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration. Blood 101: 4245-4252.
20. Zhang, Y., A. Foudi, J. F. Geay, M. Berthebaud, D. Buet, P. Jarrier, A. Jalil, W. Vainchenker, and F. Louache. 2004. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells 22: 1015-1029.
21. Sotsios, Y., G. C. Whittaker, J. Westwick, and S. G. Ward. 1999. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J. Immunol. 163: 5954-5963.
22. Fulkerson, P. C., H. Zhu, D. A. Williams, N. Zimmermann, and M. E. Rothenberg. 2005. CXCL9 inhibits eosinophil responses by a CCR3-and Rac2-dependent mechanism. Blood 106: 436-443.
23. Tybulewicz, V. L., and R. B. Henderson. 2009. Rho family GTPases and their regulators in lymphocytes. Nat. Rev. Immunol. 9: 630-644.
24. Wilkinson, P. C. 1998. Assays of leukocyte locomotion and chemotaxis. J. Immunol. Methods 216: 139-153.
25. Finley, M. J., X. Chen, G. Bardi, P. Davey, E. B. Geller, L. Zhang, M. W. Adler, and T. J. Rogers. 2008. Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor. J. Neuroimmunol. 197: 114-123.
26. Schneider, O. D., A. A. Weiss, and W. E. Miller. 2009. Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. J. Immunol. 182: 5730-5739.
27. Venetz, D., M. Ponzoni, M. Schiraldi, A. J. Ferreri, F. Bertoni, C. Doglioni, and M. Uguccioni. 2010. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Int. J. Cancer 127: 2300-2312.
28. Schreiber, T. H., V. Shinder, D. W. Cain, R. Alon, and R. Sackstein. 2007. Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm. Blood 109: 1381-1386.
29. Cinamon, G., and R. Alon. 2003. A real time in vitro assay for studying leukocyte transendothelial migration under physiological flow conditions. J. Immunol. Methods 273: 53-62.
30. Shamri, R., V. Grabovsky, J. M. Gauguet, S. Feigelson, E. Manevich, W. Kolanus, M. K. Robinson, D. E. Staunton, U. H. von Andrian, and R. Alon. 2005. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat. Immunol. 6: 497-506.
31. Shulman, Z., V. Shinder, E. Klein, V. Grabovsky, O. Yeger, E. Geron, A. Montresor, M. Bolomini-Vittori, S. W. Feigelson, T. Kirchhausen, et al. 2009. Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin. Immunity 30: 384-396.
32. Engelhardt, B. 2006. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural Transm. 113: 477-485.
33. Yokota, A., N. Murata, O. Saiki, M. Shimizu, T. A. Springer, and T. Kishimoto. 1995. High avidity state of leukocyte function-associated antigen-1 on rheumatoid synovial fluid T lymphocytes. J. Immunol. 155: 4118-4124.
34. Contento, R. L., B. Molon, C. Boularan, T. Pozzan, S. Manes, S. Marullo, and A. Viola. 2008. CXCR4-CCR5: a couple modulating T cell functions. Proc. Natl. Acad. Sci. USA 105: 10101-10106.
35. Ghandour, H., X. Cullere, A. Alvarez, F. W. Luscinskas, and T. N. Mayadas. 2007. Essential role for Rap1 GTPase and its guanine exchange factor CalDAGGEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion. Blood 110: 3682-3690.
36. Negulescu, P. A., T. B. Krasieva, A. Khan, H. H. Kerschbaum, and M. D. Cahalan. 1996. Polarity of T cell shape, motility, and sensitivity to antigen. Immunity 4: 421-430.
37. Wei, S. H., O. Safrina, Y. Yu, K. R. Garrod, M. D. Cahalan, and I. Parker. 2007. Ca2+ signals in CD4+ T cells during early contacts with antigen-bearing dendritic cells in lymph node. J. Immunol. 179: 1586-1594.
38. Tan, W., D. Martin, and J. S. Gutkind. 2006. The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4. J. Biol. Chem. 281: 39542-39549.
39. del Pozo, M. A., M. Vicente-Manzanares, R. Tejedor, J. M. Serrador, and F. Sánchez-Madrid. 1999. Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes. Eur. J. Immunol. 29: 3609-3620.
40. Faroudi, M., M. Hons, A. Zachacz, C. Dumont, R. Lyck, J. V. Stein, and V. L. Tybulewicz. 2010. Critical roles for Rac GTPases in T-cell migration to and within lymph nodes. Blood 116: 5536-5547.
41. García-Bernal, D., N. Wright, E. Sotillo-Mallo, C. Nombela-Arrieta, J. V. Stein, X. R. Bustelo, and J. Teixidó. 2005. Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1. Mol. Biol. Cell 16: 3223-3235.
42. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007.
43. Lin, Y. P., Y. J. Cheng, J. Y. Huang, H. C. Lin, and B. C. Yang. 2010. Zap70 controls the interaction of talin with integrin to regulate the chemotactic directionality of T-cell migration. Mol. Immunol. 47: 2022-2029.
44. Patrussi, L., C. Ulivieri, O. M. Lucherini, S. R. Paccani, A. Gamberucci, L. Lanfrancone, P. G. Pelicci, and C. T. Baldari. 2007. p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells. Blood 110: 1730-1738.
45. Dar, W. A., and S. J. Knechtle. 2007. CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology 120: 467-485.
46. Orsini, M. J., J. L. Parent, S. J. Mundell, A. Marchese, and J. L. Benovic. 1999. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization. [Published erratum appears in 2000 J. Biol. Chem. 275: 25876.] J. Biol. Chem. 274: 31076-31086.
47. Ali, H., R. M. Richardson, B. Haribabu, and R. Snyderman. 1999. Chemoattractant receptor cross-desensitization. J. Biol. Chem. 274: 6027-6030.
48. Patel, D. D., J. P. Zachariah, and L. P. Whichard. 2001. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin. Immunol. 98: 39-45.
49. Pablos, J. L., B. Santiago, M. Galindo, C. Torres, M. T. Brehmer, F. J. Blanco, and F. J. García-Lázaro. 2003. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J. Immunol. 170: 2147-2152.
50. Meiron, M., Y. Zohar, R. Anunu, G. Wildbaum, and N. Karin. 2008. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J. Exp. Med. 205: 2643-2655.